Table 2.

The clinical characteristics of misdiagnosed cases

Gender and age	Single or multiple	Known malignant tumor	HBV or HCV	Liver cirrhosis	Abnormal tumor markers	Imaging technique and enhancement patterns	Radiology diagnosis	Pathological diagnosis
F, 51	Single	N	N	N	N	MRI, rim-like enhancement	Probably malignancy	HSH
M, 17	Multiple	N	N	N	N	MRI + CT, no enhancement	Probably malignancy	HSH
F, 56	Single	N	N	N	N	CT + MRI, rim-like enhancement	Probably malignancy	HSH
F, 27	Multiple	N	N	N	N	MRI, no enhancement	Probably malignancy	HSH
M, 63	Single	N	N	N	CA199	CT + MRI, peripheral heterogeneous enhancement	ICC	HSH
M, 50	Multiple	N	HBV	Liver cirrhosis	CA199	CT + MRI, no enhancement	Probably malignancy	HSH
M, 53	Single	N	HBV	Liver cirrhosis	N	CT, no enhancement	Probably malignancy	HSH
F, 54	Single	ICC	HBV	N	CA199	CT, no enhancement	Metastasis	HSH
M, 52	Single	HCC	HBV	N	N	CT + MRI, rim-like enhancement	Metastasis	HSH
M, 51	Single	N	N	N	N	CT, peripheral heterogeneous enhancement	ICC	SCH
M, 48	Single	N	HBV	N	AFP CA199	CT + MRI, no enhancement	HCC	SCH
F, 34	Single	N	HBV	N	N	MRI + CT, wash-in and wash-out	HCC	SCH
F, 46	Single	N	N	N	AFP CA199	CT, no enhancement	Probably malignancy	SCH
M, 36	Multiple	N	N	N	N	CT + MRI, no enhancement	Probably malignancy	SCH
F, 60	Single	N	N	N	N	CT, no enhancement	Probably malignancy	SCH

F female, M male, N not found, elevated level of alpha-fetoprotein (AFP) and carbohydrate antigen 199 (CA199), HSH hepatic sclerosed hemangioma, SCH sclerosing cavernous hemangioma, MRI + CT MRI examination was first performed, then CT was performed for further differential diagnosis, CT + MRI CT first, then MRI for further differential diagnosis